Account
Inquiry
Tirzepatide 10mg represents a significant advancement in peptide research, specifically designed for scientific investigation into metabolic disorders. This dual agonist targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making tirzepatide 10mg particularly valuable for diabetes and weight management studies.
The molecular structure of tirzepatide 10mg features a complex arrangement with formula C225H348N48O68 and molecular weight of 4813.527g/mol. Researchers appreciate the consistent high purity levels exceeding 99.0%, ensuring reliable experimental results. The white lyophilized powder form requires proper reconstitution before application in research settings.
As a research compound, tirzepatide 10mg demonstrates promising characteristics for metabolic studies. The dual mechanism of action distinguishes tirzepatide 10mg from single-receptor agonists, providing researchers with a unique tool for comparative studies. Proper storage after reconstitution at 2°C-8°C maintains the stability and efficacy of tirzepatide 10mg throughout research protocols.
Our manufacturing facility maintains strict quality control measures for tirzepatide 10mg production. The peptide undergoes comprehensive analytical testing to verify purity and structural integrity. Researchers can confidently utilize tirzepatide 10mg in various experimental models, knowing they're working with a consistently high-quality research material.
We support research institutions with flexible packaging options for tirzepatide 10mg, accommodating various study requirements. The product is strictly intended for research purposes and should be handled by qualified professionals in controlled laboratory environments. Proper documentation accompanies each batch of tirzepatide 10mg to ensure traceability and quality assurance.
